Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to $2.3 million.

  • Accendra Health's Share-based Compensation fell 5878.52% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.9 million, marking a year-over-year decrease of 78.54%. This contributed to the annual value of $26.8 million for FY2024, which is 1558.27% up from last year.
  • According to the latest figures from Q3 2025, Accendra Health's Share-based Compensation is $2.3 million, which was down 5878.52% from $8.1 million recorded in Q2 2025.
  • In the past 5 years, Accendra Health's Share-based Compensation registered a high of $8.1 million during Q2 2025, and its lowest value of $2.3 million during Q3 2025.
  • Over the past 5 years, Accendra Health's median Share-based Compensation value was $5.8 million (recorded in 2022), while the average stood at $6.0 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 10289.18% in 2021, then plummeted by 5878.52% in 2025.
  • Accendra Health's Share-based Compensation (Quarter) stood at $5.9 million in 2021, then decreased by 11.96% to $5.2 million in 2022, then grew by 10.96% to $5.8 million in 2023, then skyrocketed by 30.24% to $7.6 million in 2024, then tumbled by 69.01% to $2.3 million in 2025.
  • Its Share-based Compensation was $2.3 million in Q3 2025, compared to $8.1 million in Q2 2025 and $6.9 million in Q1 2025.